How To Decarbonize Pharma R&D

 
• By Francesca Bruce

As the planet heats up and sea levels rise, the need to reduce carbon emissions is becoming ever more urgent. The life sciences industry is just one of many that are looking to cut the carbon it produces.  

Climate Change
Regulators across the world should collaborate to design pathways that help decarbonize drug development • Source: Shutterstock

Drug manufacturing and supply chains may be more obvious targets for slashing emissions, but so too is R&D. Researchers should look to greater collaboration, adaptive trials and slashing “low value research,” among other things, to reach net zero targets, according to speakers at the 3 September Westminster Health Forum policy conference entitled “Next steps for decarbonization in the UK life sciences sector.”

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from ESG

More from In Vivo